Clinical Trial Update: Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Unipeg® for response and ongoing safety in the Pakistani population with hepatitis C completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Unipeg®

Snippet

Sponsor: Getz Pharma | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2018-09-27